GG
SEC Insider//CIK 0001256088
GEMAYEL GEORGES
CIK 00012560889 companies
Transactions
50
Companies
9
Filings
10
CIK
0001256088
Recent Transactions
- Award
- Award
- Award
- Disposition to Issuer
- Award
- Award
Director Stock Option (Right to Buy)
2025-02-19+7,296→ 7,296 total - Sale
- Exercise/Conversion
- Exercise/Conversion
- Exercise/Conversion
- Exercise/Conversion
Director Stock Option (Right to Buy)
2024-11-07−14,213→ 10,787 total - Sale
- Exercise/Conversion
Director Stock Option (Right to Buy)
2024-09-13−10,000→ 25,000 total - Sale
- Sale
- Exercise/Conversion
- Award
- Disposition to Issuer
- Award
- Award
- Award
Director Stock Option (Right to Buy)
2024-02-22+8,252→ 8,252 total - Award
- Award
- Award
Director Stock Option (Right to Buy)
2023-02-23+6,293→ 6,293 total - Disposition to Issuer
- Award
- Award
- Award
Director Stock Option (Right to Buy)
2022-02-22+6,847→ 6,847 total - Award
- Disposition to Issuer
- Award
- Award
- Award
- Award
- Award
- Award
Director Stock Option (Right to Buy)
2021-02-19+7,365→ 7,365 total - Award
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Exercise/Conversion
- Exercise/Conversion
- Sale
- Exercise/Conversion
- Sale
- Exercise/Conversion
- Award
Companies
9ADOLOR CORP
Director
Altus Pharmaceuticals Inc.
Director, President & CEO
Dimension Therapeutics, Inc.
Director
- $IRON
Disc Medicine, Inc.
Director
GENZYME CORP
Executive Vice President
HORIZON PHARMACEUTICAL LLC
Director
MOMENTA PHARMACEUTICALS INC
Director
NPS PHARMACEUTICALS INC
Director
- $SUPN
SUPERNUS PHARMACEUTICALS, INC.
Director